Reversal of obesity-driven aggressiveness of endometrial cancer by metformin

Background: Obesity and diabetes are associated with increased risk and worse outcomes for endometrial cancer. Metformin is a widely prescribed generic drug for the treatment of type II diabetes and metabolic syndrome and may also have anti-tumorigenic effects. Thus, we assessed the metabolic anti-t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Am J Cancer Res
Hauptverfasser: Guo, Hui, Kong, Weimin, Zhang, Lu, Han, Jianjun, Clark, Leslie H, Yin, Yajie, Fang, Ziwei, Sun, Wenchuan, Wang, Jiandong, Gilliam, Timothy P, Lee, Douglas, Makowski, Liza, Zhou, Chunxiao, Bae-Jump, Victoria L
Format: Artigo
Sprache:Inglês
Veröffentlicht: e-Century Publishing Corporation 2019
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6834476/
https://ncbi.nlm.nih.gov/pubmed/31720081
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge